MA25590A1 - ACTIVE AGENT FOR DRY POWDER DELIVERY - Google Patents
ACTIVE AGENT FOR DRY POWDER DELIVERYInfo
- Publication number
- MA25590A1 MA25590A1 MA25762A MA25762A MA25590A1 MA 25590 A1 MA25590 A1 MA 25590A1 MA 25762 A MA25762 A MA 25762A MA 25762 A MA25762 A MA 25762A MA 25590 A1 MA25590 A1 MA 25590A1
- Authority
- MA
- Morocco
- Prior art keywords
- active agent
- dry powder
- powder delivery
- delivery
- dry
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Otolaryngology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10016398P | 1998-09-14 | 1998-09-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA25590A1 true MA25590A1 (en) | 2002-12-31 |
Family
ID=22278404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA25762A MA25590A1 (en) | 1998-09-14 | 1999-09-09 | ACTIVE AGENT FOR DRY POWDER DELIVERY |
Country Status (44)
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6956021B1 (en) | 1998-08-25 | 2005-10-18 | Advanced Inhalation Research, Inc. | Stable spray-dried protein formulations |
| WO2000075281A2 (en) | 1999-06-09 | 2000-12-14 | University Technology Corporation | Supercritical fluid-assisted nebulization and bubble drying |
| US6475468B2 (en) * | 2001-02-15 | 2002-11-05 | Aeropharm Technology Incorporated | Modulated release particles for aerosol delivery |
| JP2005503425A (en) * | 2001-05-24 | 2005-02-03 | アレックザ モレキュラー デリヴァリー コーポレイション | Delivery of drug ester by the prescribed inhalation route |
| EG24184A (en) * | 2001-06-15 | 2008-10-08 | Otsuka Pharma Co Ltd | Dry powder inhalation system for transpulmonary |
| US7182961B2 (en) | 2001-11-20 | 2007-02-27 | Advanced Inhalation Research, Inc. | Particulate compositions for pulmonary delivery |
| AU2003215396B2 (en) | 2002-02-25 | 2010-04-08 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
| US7759506B2 (en) | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
| JP2006513139A (en) * | 2002-07-03 | 2006-04-20 | ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド | Central airway administration for systemic delivery of therapeutic agents |
| WO2004060352A1 (en) * | 2002-12-19 | 2004-07-22 | Pharmacia Corporation | Non-hygroscopic formulation comprising a hydroscopic drug |
| DE10338403A1 (en) * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powder formulation containing the CGRP antagonist 1- [N 2 - [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1 H) -oxoquinazolin-3-yl] -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyrindinyl) piperazine, process for its preparation and its use as inhalant |
| GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| AU2005237523A1 (en) * | 2004-04-23 | 2005-11-10 | Cydex Pharmaceuticals, Inc. | DPI formulation containing sulfoalkyl ether cyclodextrin |
| UA95903C2 (en) | 2005-02-24 | 2011-09-26 | Дифьюжен Фармасьютикалз Ллк | Trans carotenoids, their synthesis, formulation and uses |
| KR20070110418A (en) * | 2005-03-09 | 2007-11-16 | 오노 야꾸힝 고교 가부시키가이샤 | Particles and Formulations Containing the Particles |
| MX383536B (en) | 2005-10-26 | 2025-03-14 | Cydex Pharmaceuticals Inc | SULFOALKYL ETHER-CYCLODEXTRIN COMPOSITIONS AND METHODS OF PREPARING SAME. |
| US7629331B2 (en) | 2005-10-26 | 2009-12-08 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| WO2008021451A2 (en) * | 2006-08-14 | 2008-02-21 | Aktiv-Dry Llc | Human-powered dry powder inhaler and dry powder inhaler compositions |
| CN101541311B (en) * | 2006-10-25 | 2013-01-23 | 大日本住友制药株式会社 | Granular preparation prevented from caking |
| EP1925295A1 (en) * | 2006-11-22 | 2008-05-28 | Boehringer Ingelheim Pharma GmbH & Co. KG | Stable powder formulation containing a new antichinolinergic agent |
| KR101570131B1 (en) | 2007-04-13 | 2015-11-18 | 디퓨젼 파마슈티컬즈 엘엘씨 | Use of bipolar transcarotenoids for the treatment and prevention of peripheral vascular disease |
| US12370352B2 (en) | 2007-06-28 | 2025-07-29 | Cydex Pharmaceuticals, Inc. | Nasal and ophthalmic delivery of aqueous corticosteroid solutions |
| JP2011502125A (en) | 2007-10-31 | 2011-01-20 | ディフュージョン・ファーマシューティカルズ・エルエルシー | A new class of treatments that promote small molecule diffusion |
| PL2432502T3 (en) | 2009-05-20 | 2018-05-30 | Aeras | Stable, spray dried, immunogenic, viral compositions |
| CN108464976A (en) | 2009-06-22 | 2018-08-31 | 扩散药品有限公司 | Diffusion promotes compound and its independent or application together with Thrombolytic Drugs |
| WO2011152869A1 (en) | 2010-06-02 | 2011-12-08 | Diffusion Pharmaceuticals Llc | Oral formulations of bipolar trans carotenoids |
| CA2866230C (en) | 2012-05-03 | 2020-08-18 | Janssen R&D Ireland | Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections |
| WO2014074797A1 (en) * | 2012-11-09 | 2014-05-15 | Civitas Therapeutics, Inc. | Ultra low density pulmonary powders |
| US20180043585A9 (en) * | 2013-09-20 | 2018-02-15 | Virginia Commonwealth University | Delivery of particles using hygroscopic excipients |
| DK3212212T3 (en) | 2014-10-31 | 2020-12-21 | Univ Monash | POWDER FORMULATION |
| CN115089569A (en) | 2016-03-24 | 2022-09-23 | 扩散药品有限公司 | Use of bipolar trans carotenoids in conjunction with chemotherapy and radiation therapy for the treatment of cancer |
| US20220378727A1 (en) * | 2021-05-14 | 2022-12-01 | The University Of Hong Kong | Dry powder formulations of tamibarotene for pulmonary and intranasal delivery |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3155573A (en) * | 1958-05-06 | 1964-11-03 | Benger Lab Ltd | Inhalant composition and method of making same |
| CA2115065C (en) * | 1992-06-12 | 2000-10-03 | Kiyoyuki Sakon | Ultrafine particle powder for inhalation and method for production thereof |
| US6524557B1 (en) * | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| PT954282E (en) * | 1997-01-16 | 2005-06-30 | Massachusetts Inst Technology | PREPARATION OF PARTICLES FOR INHALATION |
| US6086376A (en) * | 1998-01-30 | 2000-07-11 | Rtp Pharma Inc. | Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant |
-
1999
- 1999-09-09 MA MA25762A patent/MA25590A1/en unknown
- 1999-09-13 ID IDW20010582A patent/ID28845A/en unknown
- 1999-09-13 CA CA002343920A patent/CA2343920A1/en not_active Abandoned
- 1999-09-13 HR HR20010189A patent/HRP20010189A2/en not_active Application Discontinuation
- 1999-09-13 KR KR1020017003208A patent/KR20010075063A/en not_active Ceased
- 1999-09-13 EP EP99969035A patent/EP1117442A1/en not_active Withdrawn
- 1999-09-13 HK HK02101738.3A patent/HK1042231A1/en unknown
- 1999-09-13 AP APAP/P/2001/002093A patent/AP1374A/en active
- 1999-09-13 HU HU0103837A patent/HUP0103837A3/en unknown
- 1999-09-13 NZ NZ510168A patent/NZ510168A/en unknown
- 1999-09-13 AR ARP990104587A patent/AR022090A1/en unknown
- 1999-09-13 WO PCT/US1999/021109 patent/WO2000015262A1/en not_active Ceased
- 1999-09-13 IL IL14156299A patent/IL141562A0/en not_active IP Right Cessation
- 1999-09-13 JP JP2000569846A patent/JP2002524535A/en not_active Withdrawn
- 1999-09-13 AU AU60397/99A patent/AU753014B2/en not_active Ceased
- 1999-09-13 HN HN1999000159A patent/HN1999000159A/en unknown
- 1999-09-13 PE PE1999000925A patent/PE20001061A1/en not_active Application Discontinuation
- 1999-09-13 ZA ZA200101995A patent/ZA200101995B/en unknown
- 1999-09-13 CN CN99810871A patent/CN1317977A/en active Pending
- 1999-09-13 MY MYPI99003947A patent/MY129282A/en unknown
- 1999-09-13 TR TR2001/01182T patent/TR200101182T2/en unknown
- 1999-09-13 TW TW088115876A patent/TWI226248B/en not_active IP Right Cessation
- 1999-09-13 GE GEAP19995857A patent/GEP20043257B/en unknown
- 1999-09-13 CZ CZ2001829A patent/CZ2001829A3/en unknown
- 1999-09-13 SK SK344-2001A patent/SK3442001A3/en unknown
- 1999-09-13 PL PL99346768A patent/PL195574B1/en not_active IP Right Cessation
- 1999-09-13 DZ DZ990192A patent/DZ2892A1/en active
- 1999-09-13 OA OA1200100063A patent/OA11781A/en unknown
- 1999-09-13 YU YU24201A patent/YU24201A/en unknown
- 1999-09-13 UA UA2001031707A patent/UA76085C2/en unknown
- 1999-09-13 BR BR9913722-4A patent/BR9913722A/en not_active IP Right Cessation
- 1999-09-13 EA EA200100300A patent/EA003476B1/en active IP Right Revival
- 1999-09-13 EE EEP200100151A patent/EE200100151A/en unknown
- 1999-09-14 CO CO99058265A patent/CO5130023A1/en unknown
- 1999-09-14 GT GT199900156A patent/GT199900156A/en unknown
- 1999-09-14 TN TNTNSN99173A patent/TNSN99173A1/en unknown
- 1999-09-14 UY UY25711A patent/UY25711A1/en not_active Application Discontinuation
- 1999-09-14 PA PA19998481901A patent/PA8481901A1/en unknown
- 1999-10-31 SA SA99200718A patent/SA99200718B1/en unknown
-
2001
- 2001-02-21 IL IL141562A patent/IL141562A/en unknown
- 2001-03-05 IS IS5878A patent/IS5878A/en unknown
- 2001-03-13 NO NO20011251A patent/NO20011251L/en not_active Application Discontinuation
- 2001-03-14 LT LT2001021A patent/LT4897B/en not_active IP Right Cessation
- 2001-03-14 LV LV010041A patent/LV12658B/en unknown
- 2001-04-10 BG BG105430A patent/BG105430A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA25590A1 (en) | ACTIVE AGENT FOR DRY POWDER DELIVERY | |
| MA26033A1 (en) | ACTIVE AEROSOL DELIVERY AGENT | |
| IL149554A0 (en) | Fungicidal combinations of active substances | |
| IS5248A (en) | Pharmaceutical formulations containing voriconazole | |
| DE60039829D1 (en) | powder spray | |
| IS6263A (en) | Pharmaceutical formulations containing tripeptide | |
| DE69826704D1 (en) | PLEUROMUTLIN DERIVATIVES AS AN ANTIMICROBIAL ACTIVE AGENT | |
| GB0216125D0 (en) | Fibers providing controlled active agent delivery | |
| DE69923076D1 (en) | TRANSTHORACOAL MEDICAMENT DELIVERY | |
| EP1487417A4 (en) | Dry powder medicament formulations | |
| EE200000595A (en) | Delivery of the active ingredient to the carrier matrix | |
| NO20015670L (en) | Improved pharmaceutical formulations | |
| PT1227724E (en) | HERBICIDE AGENT | |
| PL349862A1 (en) | Fungicidal active substance combinations | |
| DE59902159D1 (en) | ACTIVE MICROMIC | |
| PL355623A1 (en) | Fungicidally active substance combinations | |
| NO20005880D0 (en) | Bioreductive cytotoxic agents | |
| FR2797156B1 (en) | POWDER DISPENSER | |
| DE60019505D1 (en) | Microbicidal active substances | |
| ES1048018Y (en) | PACK OF CIGARETTES. | |
| ZA200202759B (en) | Synergistic herbicidal active substance combinations. | |
| HUP0201986A2 (en) | Fungicidal combinations of active substances | |
| FR2796699B1 (en) | ROTARY POWDER DISPENSER | |
| GB2351221B (en) | Animal cage | |
| ZA200202777B (en) | Dosage unit for dry powder medicament. |